NO995290L - Anti-helicobacter vaccine composition for use of the subdiafragmatic systemic route and combined mucosal / parenteral immunization method - Google Patents

Anti-helicobacter vaccine composition for use of the subdiafragmatic systemic route and combined mucosal / parenteral immunization method

Info

Publication number
NO995290L
NO995290L NO995290A NO995290A NO995290L NO 995290 L NO995290 L NO 995290L NO 995290 A NO995290 A NO 995290A NO 995290 A NO995290 A NO 995290A NO 995290 L NO995290 L NO 995290L
Authority
NO
Norway
Prior art keywords
subdiafragmatic
immunization method
helicobacter
vaccine composition
parenteral immunization
Prior art date
Application number
NO995290A
Other languages
Norwegian (no)
Other versions
NO995290D0 (en
Inventor
Bruno Guy
Jean Haensler
Cynthia K Lee
Richard A Weltzin
Thomas P Monath
Original Assignee
Merieux Oravax
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9705609A external-priority patent/FR2762788B1/en
Application filed by Merieux Oravax filed Critical Merieux Oravax
Publication of NO995290D0 publication Critical patent/NO995290D0/en
Publication of NO995290L publication Critical patent/NO995290L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Abstract

Det beskrives anvendelse av et immunogent agens avledet fra Helicobacter, ved fremstillingen av en farmasøytisk blanding beregnet for induksjon av en T- hjelper 1 (Th1) type immunrespons mot Helicobacter, for å forhindre eller behandle en He//co6acter-infeksjon i et pattedyr. Dette oppnås særlig når den farmasøytiske blanding er ment administrert via den systemiske eller parenterale rute, for eksempel i den del av pattedyret som befinner seg under dets diafragma. Det beskrives dessuten en mukosal/parenteral immuniseringsmetode for forhindring eller behandling av Hefcobacter-infeksjon.The use of an immunogenic agent derived from Helicobacter is described in the preparation of a pharmaceutical composition intended for the induction of a T helper 1 (Th1) type immune response to Helicobacter, to prevent or treat a He / co6acter infection in a mammal. This is particularly achieved when the pharmaceutical composition is intended to be administered via the systemic or parenteral route, for example in the portion of the mammal under its diaphragm. A mucosal / parenteral immunization method is also disclosed for the prevention or treatment of Hefcobacter infection.

NO995290A 1997-04-30 1999-10-29 Anti-helicobacter vaccine composition for use of the subdiafragmatic systemic route and combined mucosal / parenteral immunization method NO995290L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9705609A FR2762788B1 (en) 1997-04-30 1997-04-30 ANTI-HELICOBACTER VACCINE COMPOSITION FOR SUB-DIAPHRAGMATIC SYSTEMIC USE
FR9715731 1997-12-08
PCT/US1998/008890 WO1998048835A1 (en) 1997-04-30 1998-04-30 Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method

Publications (2)

Publication Number Publication Date
NO995290D0 NO995290D0 (en) 1999-10-29
NO995290L true NO995290L (en) 1999-12-29

Family

ID=26233514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995290A NO995290L (en) 1997-04-30 1999-10-29 Anti-helicobacter vaccine composition for use of the subdiafragmatic systemic route and combined mucosal / parenteral immunization method

Country Status (10)

Country Link
EP (1) EP1017417A1 (en)
JP (1) JP2002512619A (en)
KR (1) KR20010020366A (en)
CN (1) CN1254292A (en)
AU (1) AU751433B2 (en)
BR (1) BR9809426A (en)
CA (1) CA2289253A1 (en)
HU (1) HUP0003388A3 (en)
NO (1) NO995290L (en)
WO (1) WO1998048835A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0029919D0 (en) * 2000-12-07 2001-01-24 Chiron Spa Helicobacter pylori prime & boost vaccination
MX368220B (en) 2008-06-27 2019-09-24 Zoetis Services Llc Novel adjuvant compositions.
CA2924526A1 (en) 2013-09-19 2015-03-26 Paul Joseph Dominowski Water-in-oil emulsions comprising immunostimulatory oligonucleotides
MX2017009306A (en) 2015-01-16 2017-11-08 Zoetis Services Llc Foot-and-mouth disease vaccine.
CN108743929B (en) * 2018-06-14 2021-07-27 四川大学 Preparation method and application of urease gel microspheres used as urea scavenger

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69334197T2 (en) * 1992-03-02 2008-12-11 Novartis Vaccines And Diagnostics S.R.L. Helicobacter pylori cytotoxin useful in vaccines and diagnostics
US5679769A (en) * 1994-03-15 1997-10-21 Sloan-Kettering Institute For Cancer Research Synthesis of asparagine-linked glycopeptides on a polymeric solid support
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
US5610060A (en) * 1994-06-24 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Isolated Helicobacter hepaticus
AR003125A1 (en) * 1995-06-01 1998-07-08 Astra Ab BACTERIAL ANTIGENS FOR THE DIAGNOSIS OF INFECTIONS WITH HELICOBACTER PYLORI, A DNA MOLECLE THAT CODES IT, A VECTOR, A HOST CELL, A PROCEDURE FOR PRODUCING THE POLIPEPTIDE, USE OF ELEPIPETICO, AND PROAPILY USE
SK165197A3 (en) * 1995-06-07 1999-01-11 Astra Ab Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics

Also Published As

Publication number Publication date
AU7276898A (en) 1998-11-24
AU751433B2 (en) 2002-08-15
BR9809426A (en) 2000-06-13
HUP0003388A3 (en) 2001-06-28
CN1254292A (en) 2000-05-24
KR20010020366A (en) 2001-03-15
JP2002512619A (en) 2002-04-23
HUP0003388A2 (en) 2001-02-28
NO995290D0 (en) 1999-10-29
WO1998048835A1 (en) 1998-11-05
EP1017417A1 (en) 2000-07-12
CA2289253A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
UA40597C2 (en) Vaccine composition, method for treatment of mammals, diseased or receptive to the infection, method for treatment of mammals with cancer, method for production of vaccine composition, composition of adjuvants
EE200200507A (en) Modified Vaccine Virus Ankara (MVA), an Inhibited Host Cell and a Pharmaceutical Composition Containing it, Preparation and Therapeutic Use of MVA
DE69426077T2 (en) ADJUVANTIES FOR VACCINE AGAINST THE RESPIRATORY SYNCITIAL VIRUS
AU4951196A (en) Vaccines for plague
KR970703164A (en) Treatment and Prevention of Helicobacter Infection (TREATMENT AND PREVENTION OF HELICOBACTER INFECTION)
ZA932491B (en) Vaccines
HUP0101464A2 (en) Mutant recombinant allergens
MX9301706A (en) VACCINE COMPOSITION FOR THE TREATMENT OF HELICOBACTER INFECTION.
HK1048434A1 (en) Influenza vaccine
NZ337885A (en) vaccine formulation of an antigen, a TH-1 inducing adjuvant and a sparingly water soluble amino acid
EP0330359A3 (en) Composition useful in the diagnosis and treating of hiv-1 infection
HUP9801560A1 (en) Vaccines containing a saponin and a sterol
HUP0401606A2 (en) West nile vaccine
HUP9801266A2 (en) Multimeric, recombinant urease vaccine
EP0232798A3 (en) Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
HK1005541A1 (en) Treatment of helicobacter associated gastroduodenal disease
HUP0104297A2 (en) Vaccine against sexually transmitted diseases
NO995290L (en) Anti-helicobacter vaccine composition for use of the subdiafragmatic systemic route and combined mucosal / parenteral immunization method
ATE222930T1 (en) ANTIGENIC DRUG FOR TREATMENT OR PREVENTION
HUP9904171A2 (en) Immunogenic peptides of foot-and-mouth disease viruses
CA2330313A1 (en) Immunization against and treatment for infection by h.pylori
IL100402A0 (en) Use of il-4 to enhance immune response to immunogens in vaccines
EP0317622A4 (en) Prevention and treatment of retroviral disease.
HUP0200162A2 (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
NZ501427A (en) Vaccine compositions comprising the Helicobacter pylori FlgE (flagella) polypeptide and a mucosal adjuvant

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application